ABSTRACT Dansylcadaverine, amantadine, and rimantadine, which have been shown to inhibit the endocytosis of a12-macroglobulin, epidermal growth factor, and vesicular stomatitis virus [Schlegel, R., Dickson, R. B., Willingham, M. C. & Proc. NatL Acad. Sci USA 79, [2291][2292][2293][2294][2295], were found to decrease phosphatidylcholine synthesis, chemotaxis, and internalization of a formylated peptide but to stimulate the incorporation of inositol into phosphatidylinositol in rabbit neutrophils. Dansylcadaverine decreased phosphatidykcholine synthesis by both the CDP-choline and transmethylation pathways and also inhibited the synthesis of phosphatidylethanolamine by the CDP-ethanolamine pathway. Dansylcadaverine had no effect on the phosphocholine, CDP-choline, or S-adenosyl-L-homocysteine pools but increased 2-fold the S-adenosyl-L-methionine pool. These results suggest that dansylcadaverine in some manner inhibited the condensation of CDP-choline with diacylglycerol to form phosphatidyicholine. Dansylcadaverine also inhibited phosphatidylcholine synthesis in human neutrophils, human fibroblasts, chicken embryo fibroblasts, rat hepatocytes, osteosarcoma cells, and neuroblastoma cells. It did not stimulate phosphatidylinositol synthesis in chicken embryo fibroblasts.
Many hormones and protein ligands, including epidermal growth factor, insulin, low density lipoproteins, and a2-macroglobulin, are internalized via receptor-mediated endocytosis (1) (2) (3) (4) . This process involves the binding of the ligand to specific cell-surface receptors, the accumulation of receptorligand complexes into coated pits, and the endocytosis of these complexes into uncoated vesicles that have been termed receptosomes (reviewed in ref. 5 ). Receptor-mediated endocytosis of many ligands is prevented by dansylcadaverine (DnsCad) and other compounds. Because many of these are substrates or inhibitors of the enzyme transglutaminase, it has been suggested that these agents might act by affecting the activity of that enzyme (6, 7) . However, the biochemical mechanism by which these compounds inhibit endocytosis is still unknown. Recently, large changes in the turnovers of phosphatidylcholine and phosphatidylinositol have been observed during receptor-mediated endocytosis of zymosan particles coated with complement (8, 9) . These changes in phospholipid synthesis prompted us to examine a number of inhibitors of receptormediated endocytosis for their effects on phospholipid synthesis in various cells and upon chemotaxis and internalization of a formylated peptide attractant by rabbit neutrophils. We find that several of these agents that inhibit endocytosis also have profound effects on phospholipid metabolism.
MATERIALS AND METHODS
Materials. DnsCad was purchased from Sigma. Dansylcadaverol (DnsCad-OH) and thiodansylcadaverine (SDnsCad) were gifts of J. E. Folk (National Institute of Dental Research). N-Formyl-Met-Leu-Phe (FMLP) was obtained from Peninsula Laboratory (San Carlos, CA) and formyl-L-NleLeu[ring-2,6-3H]Phe (Nle, norleucine; [3H]FNLP) was from New England Nuclear.
Methods. Intraperitoneal neutrophils from rabbits were isolated as described (10) . Chemotactic assays were carried out by using a modification of the Boyden chamber technique (10) . Results are expressed as the average number of neutrophils within five fields at a magnification of 900 for duplicate samples. Differences between duplicates did not exceed 10% for values above 10. Binding of [3H]FNLP (13.2 Ci/mmol; 1 Ci = 3.7 X 1010 Bq) was carried out at 40C as described (11) .
Internalization of [3H]FNLP was carried out under the same conditions as the binding assay except that the temperature was maintained at 37°C. Cells were incubated with [3H]FNLP for 30 min, at which time an excess of nonlabeled ligand was added and the amount of radioactivity internalized was measured as described in (12) . [3H]FNLP was used instead of [3H]-FMLP in the binding and internalization experiments because this ligand is not subject to oxidative inactivation by neutrophil enzymes (13) . Also, under our conditions, it was as potent an attractant as FMLP.
The incorporation of radioactive precursors into phospholipids was carried out as described (8, 9 At the end of this period, cells were treated with the various additives for 30 min and the levels of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine were measured by high-performance liquid chromatography as described (14) . Protein carboxymethylation was measured as described by Jamaluddin et al. (15) . Briefly, cell pellets, after precipitation and subsequent washing with 10% trichloroacetic acid, were treated.with 1 M borate buffer (pH 11) containing 2.5% methanol to release labeled methanol. The mixture, after standingfor 1 hr at 250C, was centrifuged, and the supernatant was extracted with toluene/isoamyl alcohol, 3:2 (vol/vol). An aliquot of the organic extract containing labeled methanol was assayed for radioactivity in a-scintillation counter to determine the [3H]CH30H that had been esterified with protein carboxyl groups.
.RESULTS FMLP attracts rabbit neutrophils (16) and binds to saturable cell-surface receptors (11) . The addition of DnsCad decreased the migration of rabbit neutrophils towards FMLP and the internalization of the attractant. However, it had no effect on the binding of [3H] FNLP to cell receptors (Table 1) . DnsCad-OH, an analogue of DnsCad that is ineffective in preventing -the uptake of a2-macroglobulin in fibroblasts (17) , had no effect on either chemotaxis or internalization of the attractant. DnsCad also decreased the incorporation of [methyl-3H]choline. into phospholipids (Fig. 1) . Phosphatidylcholine was the only phospholipid labeled after the addition of [methyl-3H]-choline (not shown). Phospholipids also were synthesized via (Fig. 1) . (Fig. lA) , and inhibition of choline incorporation into phospholipids by DnsCad (Fig. 1B) In contrast to its inhibitory effects on the turnover of most phospholipids, DnsCad stimulated up to 5-fold the incorporation of labeled inositol into phosphatidylinositol by rabbit neutrophils (Fig. 2) . Phosphatidylinositol was the only labeled phospholipid detected after the addition of [3H]myoinositol (not shown). Because high concentrations of DnsCad decreased the uptake of myoinositol by -20%, the maximal stimulation of inositol incorporation must be higher than that observed. It is not likely that the effects of DnsCad are the result of its inhibition of transport of the labeled precursors into the cell. At high levels of DnsCad (500 MLM), there was, at most, a 10% decrease in uptake of labeled compound. Also, the pool sizes of intermediates were not decreased. Finally, DnsCad has opposite effects upon the incorporation of choline into phosphatidylcholine on one hand and inositol into phosphatidylinositol on the other hand, a result quite difficult to explain from the action of DnsCad upon transport alone. The stimulatory effect of DnsCad on phosphatidylinositol synthesis was not observed in chicken embryo fibroblasts. In fact, at 100 AM DnsCad, there was no effect on phosphatidylinositol synthesis in these cells. The potencies of various compounds both as inhibitors of chemotaxis and phosphatidylcholine synthesis and as activators of phosphatidylinositol synthesis are shown in Table 3 . The order of potencies is: DnsCad > rimantadine > amantadine. DnsCad-OH and putrescine were inactive. 
DISCUSSION
The present studies show that a number of compounds having the ability to prevent the internalization of protein ligands (6, 7, 17) and viruses (18) (1983) volved in the activation of cell motility. DnsCad did not inhibit phospholipase A2 in neutrophils (not shown). Yet if phosphatidylcholine is the major substrate for the liberation of arachidonate, then diminished synthesis of this phospholipid could lead to a reduction in the chemotactic response.
The inhibition of endocytosis by DnsCad and related compounds has been shown to involve ligands taken up by the receptor-mediated pathway (6, 7) and by fluid-phase endocytosis (21, 22) . The major morphological pathway of receptor-mediated endocytosis involves coated pits and receptosomes. In resting fibroblasts, the major route of fluid-phase uptake is probably also via coated pits and receptosomes (23) .
The mechanism by which DnsCad perturbs phospholipid metabolism is not yet known. It has been shown that DnsCad is taken up principally by plasma membranes of a variety of cells (24) . One site of its inhibitory action may be upon phosphatidylcholine synthesis through the CDP-choline pathway, because DnsCad apparently acts at a step beyond the synthesis of CDP-choline. In cell-free extracts DnsCad inhibits the activity of phosphocholine transferase (data not shown). This enzyme, which is found in the microsomal cell fraction (25) , catalyzes the synthesis of phosphatidylcholine from CDPcholine and diacylglycerol (26) . At higher concentrations DnsCad also inhibits the synthesis of phosphatidylethanolamine by the CDP-ethanolamine pathway. Both inhibitions may result in an accumulation of diacylglycerol because it would not be used either for the synthesis of phosphatidylcholine or for phosphatidylethanolamine. The inhibition of the synthesis of phosphatidylethanolamine, the substrate for the synthesis of phosphatidylcholine by the transmethylation pathway (27) , may also account for the decreased incorporation of the methyl group of methionine into phospholipids under conditions in which the pool of S-adenosyl-L-methionine is increased. In favor of this last hypothesis is the observation that the doseresponse curves for the inhibition by DnsCad of the synthesis of phosphatidylcholine by transmethylation and the synthesis of phosphatidylethanolamine are very similar.
Taking into account the marked inhibitory effects of compounds like DnsCad upon phosphatidylcholine synthesis in a variety of cell types, it seems possible that these agents might inhibit cellular functions such as endocytosis and chemotaxis by profoundly altering phospholipid metabolism.
